Craig Gedye

An Immune Atlas of Clear Cell Renal Cell Carcinoma

Stéphane Chevrier, Jacob Levine, Vito Riccardo Tomaso Zanotelli et al. · Cell · 2017 · 1K citations · Full text

Urology, Cancer Immunosurveillance, Immune Atlas +5

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1K citations

Urology, Oncology, Genitourinary Cancer +7

Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide

Anthony J. Kettle, Craig Gedye, Christine C. Winterbourn · Biochemical Journal · 1997 · 239 citations · Full text

PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

James P Buteau, Andrew Martin, Louise Emmett et al. · The Lancet Oncology · 2022 · 239 citations

Biomarker (Medicine), Prognostic Biomarkers, Urology +7

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

Jocelyn M. Stewart, Patricia A. Shaw, Craig Gedye et al. · Proceedings of the National Academy of Sciences · 2011 · 204 citations